Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Mesenchymal stromal cells and natural killer cells: a complex story of love and hate.

Auteurs : Najar M, Fayyad-Kazan M, Merimi M, Burny A, Bron D, Fayyad-Kazan H, Meuleman N, Lagneaux L
Jaar : 2019
Journal : Curr Stem Cell Res Ther
Volume : 14(1)
Pagina's : 14-21

MiR302c, Sp1, and NFATc2 regulate interleukin-21 expression in human CD4+CD45RO+ T lymphocytes.

Auteurs : El-Said H, Fayyad-Kazan M, Aoun R, Borghol N, Skafi N, Rouas R, Vanhamme L, Mourtada M, Ezzeddine M, Burny A, Fayyad-Kazan H, Badran B
Jaar : 2019
Journal : J Cell Physiol
Volume : 234
Pagina's : 5998-6011

Empowering the immune fate of bone marrow mesenchymal stromal cells: gene and protein changes.

Auteurs : Najar M, Ouhaddi Y, Bouhtit F, Melki R, Afif H, Boukhatem N, Merimi M, Fahmi H
Jaar : 2019
Journal : Inflamm Res
Volume : 68(2)
Pagina's : 167-176

Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Auteurs : Najar M, Fayyad-Kazan H, Faour WH, Merimi M, Sokal EM, Lombard CA, Fahmi H
Jaar : 2019
Journal : Inflamm Res
Volume : 68
Pagina's : 203-213

Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report.

Auteurs : Nelis S, Azerad MA, Drowart A, Lewalle P, Efira A
Jaar : 2019
Journal : Rev Med Interne
Volume : 40
Pagina's : 258-261

Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Auteurs : Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S
Jaar : 2019
Journal : Bull Cancer
Volume : 106
Pagina's : S23-S34

Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells.

Auteurs : Najar M, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2019
Journal : Cytotechnology
Volume : 71
Pagina's : 375-388

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD.

Auteurs : Socié G, Milpied N, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Lewalle P, Liens D, Mathis C, Guemas E, Vernant JP
Jaar : 2019
Journal : Blood Adv
Volume : 3
Pagina's : 184-186

Human CD8<sup>+</sup> CD25 <sup>+</sup> CD127 <sup>low</sup> regulatory T cells: microRNA signature and impact on TGF-ß and IL-10 expression.

Auteurs : Rouas R, Merimi M, Najar M, Zein NE, Fayyad-Kazan M, Berehab M, Agha D, Bron D, Burny A, Rachidi W, Badran B, Lewalle P, Fayyad-Kazan H
Jaar : 2019
Journal : J Cell Physiol

Th17 immune response to adipose tissue-derived mesenchymal stromal cells.

Auteurs : Najar M, Lombard CA, Fayyad-Kazan H, Faour WH, Merimi M, Sokal EM, Lagneaux L, Fahmi H
Jaar : 2019
Journal : J Cell Physiol

Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges.

Auteurs : Najar M, Bouhtit F, Melki R, Afif H, Hamal A, Fahmi H, Merimi M, Lagneaux L
Jaar : 2019
Journal : J Clin Med
Volume : 8

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.

Auteurs : Devos T, Verhoef G, Steel E, Mazure D, Lewalle P, Bron D, Berneman Z, Benghiat FS, Mineur P, Theunissen K, Zachée P, Doyen C, Put N, Lejeune M, Van Eygen K, Havelange V, Reusens M, Pluymers W, Peeters K
Jaar : 2019
Journal : Acta Haematol
Pagina's : 1-11

The Micronome of Mesenchymal Stromal Cells is partially responsive to Inflammation.

Auteurs : Fayyad-Kazan H, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Jaar : 2018
Journal : Cell Biol Int
Volume : 42(2)
Pagina's : 254-260

Immunomodulatory effects of foreskin mesenchymal stromal cells (FSK-MSCs) on natural killer (NK) cells.

Auteurs : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2018
Journal : J Cell Physiol
Volume : 233(7)
Pagina's : 5243-54

Immuno-biological comparison of hepatic stellate cells in a reverted and activated state.

Auteurs : Najar M, Fayyad-Kazan H, Faour WH, El Taghdouini A, Raicevic G, van Grunsven LA, Najimi M, Sokal E, Lagneaux L
Jaar : 2018
Journal : Biomed Pharmacother
Volume : 98
Pagina's : 52-62

Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Auteurs : Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, Raicevic G, Lagneaux L
Jaar : 2018
Journal : Inflamm Res
Volume : 67(6)
Pagina's : 467-477

Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Auteurs : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2018
Journal : J Cell Commun Signal
Volume : 12(4)
Pagina's : 673-688

First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.

Auteurs : Tarhini M, Fayyad-Kazan M, Fayyad-Kazan H, Mokbel M, Nasreddine M, Badran B, Kchour G
Jaar : 2018
Journal : Microb Pathog
Volume : 117
Pagina's : 23-26

T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).

Auteurs : Sestili S, Labopin M, Ruggeri A, Velardi A, Ciceri F, Maertens J, Kanz L, Aversa F, Lewalle P, Bunjes D, Mohty M, Nagler A
Jaar : 2018
Journal : Cancer
Volume : 124(10)
Pagina's : 2142-2150

Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.

Auteurs : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2018
Journal : Mol Cell Biochem
Volume : 447(1-2)
Pagina's : 111-124